Cardiac arrest & resuscitation

Epinephrine in Out-of-Hospital Cardiac Arrest: A Network Meta-analysis and Subgroup Analyses of Shockable and Nonshockable Rhythms

ChestPublished Systematic review and network meta-analysis of randomised trials

Authors' conclusion

Use of standard-dose epinephrine, high-dose epinephrine, and epinephrine plus vasopressin increases ROSC and survival to hospital admission, but may not improve survival to discharge or functional outcome.

Study context

Population
Patients with out-of-hospital cardiac arrest (OHCA) in RCTs evaluating epinephrine use during resuscitation (6 databases, inception through June 2022)
Participants
21,594 patients · 18 trials
Comparison
Standard-dose epinephrine, high-dose epinephrine, epinephrine plus vasopressin vs placebo or no treatment
Outcome
Return of spontaneous circulation (ROSC)
Methodological detailsfrequentist random-effects network meta-analysis, GRADE certainty of evidence
  • Frequentist random-effects network meta-analysis
  • GRADE certainty of evidence

Pooled result

As reported in the abstract

Each group vs placebo or no treatmentOR for ROSC (95% CI)
High-dose epinephrine
4.27(3.68–4.97)
Standard-dose epinephrine
3.69(3.32–4.10)
Epinephrine plus vasopressin
3.54(2.94–4.26)

Further pooled results

OutcomeEstimate
Survival to hospital admissionHigh-dose epinephrine vs Placebo or no treatmentOR for survival to hospital admission 3.53 (95% CI 2.97–4.20)
Survival to hospital admissionStandard-dose epinephrine vs Placebo or no treatmentOR for survival to hospital admission 3.00 (95% CI 2.66–3.38)
Survival to hospital admissionEpinephrine plus vasopressin vs Placebo or no treatmentOR for survival to hospital admission 2.79 (95% CI 2.27–3.44)
Survival to discharge, nonshockable vs shockable rhythm (subgroup)Standard-dose epinephrine vs Placebo or no treatment · nonshockable rhythmOR for survival to discharge (nonshockable rhythm) 2.10 (95% CI 1.21–3.63)
Survival to discharge, nonshockable vs shockable rhythm (subgroup)Standard-dose epinephrine vs Placebo or no treatment · shockable rhythmOR for survival to discharge (shockable rhythm) 0.85 (95% CI 0.39–1.85)

Survival to discharge and survival with good functional outcome

None of the agents may increase survival to discharge or survival with good functional outcome vs placebo or no treatment

Original publication

Epinephrine in Out-of-Hospital Cardiac Arrest: A Network Meta-analysis and Subgroup Analyses of Shockable and Nonshockable Rhythms. Chest. Published 31 January 2023. doi:10.1016/j.chest.2023.01.033

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.